Pages that link to "Q36250195"
The following pages link to Human CD8+ T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated With Distinct Patterns of Protein Targets (Q36250195):
Displaying 50 items.
- Human T cell responses to Japanese encephalitis virus in health and disease (Q24289630) (← links)
- Aspects of T Cell-Mediated Immunity Induced in Mice by a DNA Vaccine Based on the Dengue-NS1 Antigen after Challenge by the Intracerebral Route (Q27321668) (← links)
- Drivers of Inter-individual Variation in Dengue Viral Load Dynamics (Q27882968) (← links)
- Dengue: knowledge gaps, unmet needs, and research priorities (Q28729764) (← links)
- Patterns of cellular immunity associated with experimental infection with rDEN2Δ30 (Tonga/74) supports its suitability as a human DENV challenge strain (Q28729784) (← links)
- Human CD4+ T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection, in magnitude, HLA restriction and antigen specificity (Q28733418) (← links)
- Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells (Q28950660) (← links)
- In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination (Q30250977) (← links)
- CD4+ and CD8+ T-cell immunity to Dengue - lessons for the study of Zika virus (Q30394327) (← links)
- Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype (Q35935142) (← links)
- Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area. (Q36263779) (← links)
- Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection (Q37604714) (← links)
- T-cell Responses in Individuals Infected with Zika Virus and in Those Vaccinated Against Dengue Virus. (Q38156586) (← links)
- Achieving safe, effective, and durable Zika virus vaccines: lessons from dengue (Q38157807) (← links)
- Analysis of cell-mediated immune responses in support of dengue vaccine development efforts (Q38605194) (← links)
- Immune correlates of protection for dengue: State of the art and research agenda (Q38652971) (← links)
- Immune-mediated cytokine storm and its role in severe dengue (Q39236667) (← links)
- Pathogenesis of vascular leak in dengue virus infection (Q39258872) (← links)
- Development of Peptide Vaccines in Dengue. (Q40038715) (← links)
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? There Is Only One True Winner (Q40047872) (← links)
- A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue viruses (Q40061824) (← links)
- HLA-DRB1 Alleles Are Associated With Different Magnitudes of Dengue Virus-Specific CD4+ T-Cell Responses (Q40095654) (← links)
- Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans (Q41924182) (← links)
- Dengue infection. (Q42996339) (← links)
- Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas (Q43047038) (← links)
- T Cell Immunity to Zika and Dengue Viral Infections (Q46518619) (← links)
- Plant-expressed Fc-fusion protein tetravalent dengue vaccine with inherent adjuvant properties. (Q47265866) (← links)
- Regulatory T-cells in acute dengue viral infection (Q47400186) (← links)
- Immune Response to Dengue and Zika (Q47551925) (← links)
- Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL. (Q47558388) (← links)
- Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age. (Q47898513) (← links)
- Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development. (Q51336680) (← links)
- Predicting HLA CD4 Immunogenicity in Human Populations. (Q55383910) (← links)
- Innate immune receptors drive dengue virus immune activation and disease. (Q55387054) (← links)
- Cross-reactive Dengue virus-specific CD8 T cells protect against Zika virus during pregnancy (Q56341981) (← links)
- Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone (Q56986149) (← links)
- A Review on T Cell Epitopes Identified Using Prediction and Cell-Mediated Immune Models for Mycobacterium tuberculosis and Bordetella pertussis (Q59800431) (← links)
- Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine? (Q62485190) (← links)
- T-Cell Response to Viral Hemorrhagic Fevers (Q63246534) (← links)
- Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses (Q66679225) (← links)
- T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification (Q66679253) (← links)
- A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice (Q66679555) (← links)
- Longitudinal Analysis of Memory B and T Cell Responses to Dengue Virus in a 5-Year Prospective Cohort Study in Thailand (Q66679636) (← links)
- Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development (Q66679685) (← links)
- Dengue-specific CD8+ T cell subsets display specialized transcriptomic and TCR profiles (Q66680670) (← links)
- Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America (Q89453187) (← links)
- T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species (Q90051666) (← links)
- Human T Cell Response to Dengue Virus Infection (Q90266052) (← links)
- Association of dengue virus-specific polyfunctional T-cell responses with clinical disease severity in acute dengue infection (Q90376640) (← links)
- Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial (Q90707501) (← links)